Digestive and Liver Disease

Papers
(The H4-Index of Digestive and Liver Disease is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma62
Autoimmune atrophic gastritis and coeliac disease: A case-control study61
Inflammatory bowel disease epidemiology data from a prospective registry in Córdoba, Argentina: Raising the bar for future studies in Latin America59
T.10.4 INTESTINAL ULTRASONOGRAPHY PROFILING OF PATIENTS WITH CROHN'S DISEASE PREDICTS LONG TERM CLINICAL REMISSION50
Editorial Board50
Do glucagon-like peptide-1 based therapies alter the risk of late-onset inflammatory bowel disease?50
AF.82 THE ROLE OF THE PNPLA3, TM6SF2 AND MBOAT7 GENETIC VARIANTS IN THE RESPONSE TO NUTRACEUTICAL THERAPY FOR NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS48
T.11.7 THE PROGNOSTIC ROLE OF RADIOMICS IN GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMORS46
AF.83 USEFULNESS OF ELASTOMETRY IN EVALUATING THE EXTENTS OF LIVER FIBROSIS AND RISK OF NON HEPATIC COMPLICATION IN NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN DIABETIC PATIENTS TYPE 2 (DM2)46
AF.112 ENDOROTOR-BASED ENDOSCOPIC NECROSECTOMY IN COMPLICATED WALLED-OFF PANCREATIC NECROSIS: A CASE REPORT44
V.01.7 COMPLETE INTRA-PERITONEAL MALDEPLOYMENT OF A LAMS DURING EUS-GEA FOR MGOO: RESCUE RETRIEVAL WITH PERITONEOSCOPY THROUGH NOTES41
Application of Machine Learning Model-3P to Predict Portal Hypertension in Patient with Hepatocellular Carcinoma40
Evaluation of allelic frequency and genetic risk score of non-alcoholic fatty liver disease in a population of Southern Italy39
Does HLA-G play a role in PBC?39
Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome - acute kidney injury37
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network35
Impact of ISO score on oncological outcomes and survival in liver transplant candidates with hepatocellular carcinoma33
Impact of laparoscopic liver resection for access to the waiting list of a single regional liver transplant center in southern Italy: entry and dropout flows’ analysis33
The impact of bacterial infections on cirrhosis complications in a cohort of cirrhotic patients in a northern Italian hospital31
Liposomal doxorubicin targeted with the Fab' of atezolizumab as a novel strategy against HCC31
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis31
Recurrent IgG4 cholangitis after liver transplantation: Back to the future29
Comment on “Effect of vessels that encapsulate tumor clusters (VETC) and different stages of hepatocellular carcinoma after hepatectomy”29
Assessment of sarcopenia with ultrasound-based measurements in patients with liver cirrhosis and correlation with clinical outcomes28
Brain metastasis from hepatic cholangiolocellular carcinoma in a young female without chronic liver disease28
An unusual lesion of the gallbladder mimicking gallbladder carcinoma28
Identification of causes and patterns of albumin structural damages in commercial formulations27
Cardiometabolic risk factors and clinical course of liver cirrhosis27
0.0865478515625